Executive Director, New Jersey Medical School (NJMS), Rutgers Biomedical and Health Sciences
Dr. Perlin is Executive Director of the Public Health Research Institute (PHRI) and the Rutgers Regional Biocontainment Laboratory (RBL) of New Jersey Medical School (NJMS), Rutgers Biomedical and Health Sciences. He is also a Professor of Microbiology, Biochemistry and Molecular Genetics at NJMS. Dr. Perlin is an internationally recognized expert and research scientist in infectious diseases who has played a major role in advancing the national research agenda in biodefense and emerging infectious diseases. His primary expertise is in fungal infections, mechanisms of antifungal drug resistance, and rapid diagnosis of opportunistic drug resistant bacterial and fungal pathogens in high-risk patients. Dr. Perlin is the editor-in-chief of the new open access "Journal of Fungi." He serves on the Board of Directors of the Aaron Diamond AIDS Research Center, and on advisory boards and committees for the Clinical and Laboratory Standards Institute (CLSI), Leading International Fungal Education (LIFE), various pharmaceutical and biotech companies, PinnacleCare and the American Society for Microbiology (ASM). Dr. Perlin also serves on advisory and planning boards for several major international conferences, and he is a member of the Steering Committee for Microbiology, Immunology & Infectious Diseases of the New York Academy of Sciences. He earned a Ph.D. from Cornell University and pursued postdoctoral studies at the Yale University School of Medicine and the University of Rochester School of Medicine and Dentistry. Dr. Perlin was named a Fellow of the New York Academy of Sciences in 2005, and a Visiting Professor at the University of Manchester, UK in 2009.